Switzerland
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -1.56 B
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
2 |
USD -770.00 M
|
Dec. 31, 2023 | USD 53.44 | -2.48% |
|
Switzerland |
|
3 |
USD -734.00 M
|
Dec. 27, 2024 | USD 145.06 | -1.97% |
|
Switzerland |
|
4 |
USD -440.29 M
|
Dec. 31, 2023 | USD 21.48 | -1.50% |
|
Switzerland |
|
5 |
USD -232.80 M
|
Dec. 31, 2023 | USD 77.54 | -2.09% |
|
Switzerland |
|
6 |
USD -225.00 M
|
Dec. 31, 2023 | USD 138.90 | -2.86% |
|
Switzerland |
|
7 |
USD -216.50 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
8 |
USD -206.67 M
|
Dec. 31, 2023 | USD 123.59 | -1.86% |
|
Switzerland |
|
9 |
USD -162.83 M
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
|
10 |
USD -90.75 M
|
Dec. 31, 2023 | USD 126.21 | -1.33% |
|
Switzerland |
|
11 |
USD -79.06 M
|
Dec. 31, 2023 | USD 18.55 | 4.00% |
|
Switzerland |
|
12 |
USD -70.67 M
|
Dec. 31, 2023 | USD 149.09 | -2.08% |
|
Switzerland |
|
13 |
USD -68.89 M
|
Dec. 31, 2023 | USD 136.23 | -2.52% |
|
Switzerland |
|
14 |
USD -63.77 M
|
Dec. 31, 2023 | USD 15.37 | -2.72% |
|
Switzerland |
|
15 |
USD -62.83 M
|
Dec. 31, 2023 | USD 13.36 | -0.81% |
|
Switzerland |
|
16 |
USD -58.54 M
|
Dec. 31, 2023 | USD 694.24 | -2.11% |
|
Switzerland |
|
17 |
USD -53.80 M
|
Dec. 31, 2023 | USD 920.93 | -4.05% |
|
Switzerland |
|
18 |
USD -50.72 M
|
Dec. 31, 2023 | USD 94.93 | -2.33% |
|
Switzerland |
|
19 |
USD -45.56 M
|
Dec. 31, 2023 | USD 217.97 | -2.36% |
|
Switzerland |
|
20 |
USD -42.14 M
|
Dec. 31, 2023 | USD 1.14 K | -1.12% |
|
Switzerland |
|
21 |
USD -41.91 M
|
Dec. 31, 2023 | USD 457.43 | 0.78% |
|
Switzerland |
|
22 |
USD -41.50 M
|
Dec. 31, 2023 | USD 250.45 | -3.26% |
|
Switzerland |
|
23 |
USD -38.13 M
|
Dec. 31, 2023 | USD 482.81 | -3.37% |
|
Switzerland |
|
24 |
USD -37.97 M
|
Dec. 31, 2023 | USD 16.46 | -0.32% |
|
Switzerland |
|
25 |
USD -33.89 M
|
Dec. 31, 2023 | USD 141.68 | -4.18% |
|
Switzerland |
|
26 |
USD -33.33 M
|
Dec. 31, 2023 | USD 6.75 | -1.21% |
|
Switzerland |
|
27 |
USD -32.31 M
|
March 31, 2024 | USD 917.66 | -3.06% |
|
Switzerland |
|
28 |
USD -31.37 M
|
Dec. 31, 2023 | USD 290.45 | -3.89% |
|
Switzerland |
|
29 |
USD -23.43 M
|
Dec. 31, 2023 | USD 1.25 K | -3.17% |
|
Switzerland |
|
30 |
USD -23.04 M
|
Dec. 31, 2023 | USD 340.04 | -5.35% |
|
Switzerland |
|
31 |
USD -22.34 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
32 |
USD -21.74 M
|
Dec. 31, 2023 | USD 302.44 | -2.41% |
|
Switzerland |
|
33 |
USD -15.09 M
|
Dec. 31, 2023 | USD 73.02 | -1.82% |
|
Switzerland |
|
34 |
USD -12.05 M
|
Dec. 31, 2023 | USD 42.50 | -0.65% |
|
Switzerland |
|
35 |
USD -10.31 M
|
Dec. 31, 2023 | USD 60.16 | -1.72% |
|
Switzerland |
|
36 |
USD -10.12 M
|
Dec. 31, 2023 | USD 16.95 | -4.34% |
|
Switzerland |
|
37 |
USD -9.69 M
|
Dec. 31, 2023 | USD 10.64 | -2.82% |
|
Switzerland |
|
38 |
USD -8.94 M
|
March 31, 2024 | USD 13.95 | -1.42% |
|
Switzerland |
|
39 |
USD -3.22 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
40 |
USD -3.02 M
|
Dec. 31, 2023 | USD 3.18 | -0.94% |
|
Switzerland |
|
41 |
USD -2.24 M
|
Dec. 31, 2023 | USD 23.76 | 0.27% |
|
Switzerland |
|
42 |
USD -951.38 K
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
43 |
USD -387.20 K
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
44 |
USD -284.63 K
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
45 |
USD -57.01 K
|
Dec. 31, 2023 | USD 22.91 | 2.51% |
|
Switzerland |
The 3D Printing company in Switzerland with the highest Capital Expenditure is Lonza Group AG (Swiss Stock Exchange: LONN.SW) at USD -1.56 B.
The 3D Printing company in Switzerland with the lowest Capital Expenditure is Oculis Holding AG (NasdaqGM: OCS) at USD -57.01 K.
The top 10 3D Printing companies in Switzerland by Capital Expenditure are Lonza Group AG, ABB Ltd, TE Connectivity Ltd., SIG Group AG, Georg Fischer AG, Straumann Holding AG, Ypsomed Holding AG, SFS Group AG, Siegfried Holding AG and Medacta Group SA.
The bottom 10 3D Printing companies in Switzerland by Capital Expenditure are Oculis Holding AG, MoonLake Immunotherapeutics, Kuros Biosciences AG, AC Immune SA, Schlatter Industries AG, SEALSQ Corp, ADC Therapeutics SA, Klingelnberg AG, Trifork Holding AG and Mikron Holding AG.